Back to results
US 2022/0087996 A1Published application
Histone acetylase p300 inhibitor and use thereof
AssigneeHinova Pharmaceuticals Inc.
InventorsLei FAN, Fei WANG, Xiaoquan WU, Kexin XU, Ke CHEN, Tongchuan LUO, Shaohua ZHANG, Wu DU, Chengzhi ZHANG, Yongxu HUO, Zhilin TU, Xinghai LI, Yuanwei CHEN
Life of this patent
Estimating the term…
Abstract
A compound represented by formula (I), or a stereochemical isomer thereof, or a solvate thereof, or a pharmaceutically acceptable salt thereof, can inhibit the activity of histone acetylase p300 and inhibit the proliferation activity of a variety of tumor cells.
Claims19
Compound of formula (I) or a stereoisomer, a solvate or a pharmaceutically acceptable salt, or an isotope-substituted form thereof:
- Wherein, A is selected from O, N and S;
- Ry is selected from none, H, alkyl, substituted alkyl or alkenyl;
- Each of Rv, Rw, and Rx is independently selected from the group consisting of H, halogen, cyano, nitro, alkyl, substituted alkyl, alkenyl, alkynyl, cycloalkyl, substituted cycloalkyl, heterocyclyl, substituted heterocyclyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, substituted amides, substituted guanidyl, substituted carbamido, amino, substituted amino, alkoxyl, substituted alkoxyl;
- Each of R1, R2, R3, and R4 is independently selected from the group consisting of H, alkyl, halogen;
- or, for R1, R2, R3, and R4, R1 and R2 are linked to form a ring, R2 and R3 are linked to form a ring, and/or R3 and R4 are linked to form a ring;
- R5 is selected from the group consisting of alkyl, alkoxyl, amino, substituted amino, amide, substituted amides, ester group, carbonyl, heterocyclyl, substituted heterocyclyl.
3 more elements
Dependencies are inferred from the claim text.